Private Sector Global Health R&D Project

BrookingsGov

Launched in 2016, the Brookings Private Sector Global Health R&D Project seeks to identify financial incentives to spur private sector investment in medications for developing countries in Asia and Africa.

Governance Studies

Home
About the project

Assessing Pharma’s constraints, opportunities, and investment options in global health R&D: An analysis of SEC 10-K filings

April 24, 2018

University of New England biomedical research lab manager Brittany Roy works in Ian Meng's laboratory in Biddeford

Technology & Information Assessing the challenges, opportunities, and investment options in global health R&D

Jake Schneider

April 24, 2018

Technology & Information How profitable are HIV drugs?

Jake Schneider, Darrell M. West

April 16, 2018

Public Health Measuring revenue streams and profitability for HIV drugs

Darrell M. West, Jake Schneider

April 16, 2018

Experts

John Villasenor Nonresident Senior Fellow - Governance Studies, Center for Technology Innovation (CTI)

See more experts

Filter by

results at a time

Private Sector Global Health R&D Project

Private Sector Global Health R&D Project

Experts

Select experts

Select program

Select topics

Select regions

Filter by